ProMIS Neurosciences is focused on the treatment of Alzheimer’s disease, amyotrophic lateral sclerosis and multiple system atrophy through the discovery and development of antibodies selective for toxic misfolded proteins driving these diseases.
Promis Neurosciences Neurodegenerative Disease Companies Promis Neuroscience Expert Panel Press Release Promis Canadian Public Comapny